Q97912216

Summary

Q97912216 is an individual motion^[1].

Key Facts

• Q97912216 authored Ulla Löfgren^[2].
• Q97912216 authored Maud Ekendahl^[3].
• Q97912216's instance of is recorded as individual motion^[4].
• Q97912216's part of the series is recorded as motions of the 2004-2005 legislative session of the Riksdag^[5].
• Q97912216's language of work or name is recorded as Swedish^[6].
• Q97912216 was released on +2005-03-03T00:00:00Z^[7].
• Q97912216's main subject is medication^[8].
• Q97912216's work available at URL is recorded as http://data.riksdagen.se/dokument/GS02So8^[9].
• Q97912216's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GS02So8^[10].
• Q97912216's applies to jurisdiction is recorded as Sweden^[11].
• Q97912216's legal citation of this text is recorded as Mot. 2004/05:So8^[12].
• Q97912216's title is recorded as med anledning av prop. 2004/05:70 Ökad patientsäkerhet på läkemedelsområdet^[13].
• Q97912216's has immediate cause is recorded as Q98138519^[14].
• Q97912216's cites work is recorded as Q98138519^[15].
• Q97912216's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q97912216's copyright status is recorded as public domain^[17].
• Q97912216's legislative committee is recorded as Committee on Health and Welfare^[18].

Body

Definition and Type

Q97912216's instance of is recorded as individual motion^[4].